CTRI/2017/06/008773进行中（未招募）2 期
Clinical evaluation of Ayurvedic formulation in the Management of Parikartika(Fissure in Ano) - Parikartika(FIA)
CCRASNew Delhi0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patient of Fissure in Ano of either sex .
- •1)Patients of either sex aged 18 â??60 years.
- •2)Presence of Fissure in Ano
- •confirmed by DRE / proctoscopic
- •examination
- •3)Willing and able to participate for 06 weeks.
排除标准
- •CLINICAL EVALUATION OF AYURVEDIC FORMULATION IN THE MANAGEMENT OF PARIKARTIKA (FISSURE IN ANO)
- •CASE REPORT FORM I â?? SCREENING
- •BEFORE TREATMENT
- •(Enter a ï?? in the appropriate box)
- •1.Centre Code: _____________
- •2.OPD No:_________________
- •3.Name of the Subject : _________________
- •4.Subject Sl. No.: _____________
- •5. Gender: Male (1) Female (2)
- •6.Age: __________years and __________ months
- •7.Date of birth
- •DD M M Y Y Y Y
- •8.Address:_______________________________________________________
- •_______________________________________________________
- •9.Telephone No: _______________________
- •10.Criteria for Inclusion Yes (1) No (0)
- •1)Patients of either sex aged 18 â??60 years.
- •2)Presence of Fissure in Ano
- •confirmed by DRE / proctoscopic
- •examination
- •3)Willing and able to participate for 06 weeks.
- •(For the inclusion â??YES to 1, 2 & 3â?? are compulsory)
- •11.Exclusion Criteria Yes (1) No (0)
- •1. Age below 18 years & above 60 years
- •2.Ulcerative colitis/Crohnâ??s disease
- •3.Patients of Malignancy/Tubercular/Syphilis/HIV/HbsAg/Bleeding disorders
- •4.Pregnancy and lactation
- •5.Patient who cannot report in person once in a week in the OPD
- •6.Patients with poorly controlled Hypertension( >160/100 mm Hg)
- •7.Patients with poorly controlled Diabetes Mellitus having HbA1C >8
- •8.Patients suffering from major systemic illness (Cardiac/Pulmonary/Hepatic/Renal disorders or any other conditions that may jeoparadise the study.
- •9.Alcoholics,Smokers and or drug abusers.
- •10.H/o hypersensitivity to any of the trial drugs or their ingredients.
- •11.Patients who have completed participation in any other clinical trial during the past six (06) months.
- •(For the Exclusion â??YES to any of the above)
- •Laboratory Examination:
- •ï??Haematology
- •oHaemoglobin : _____________________ g/dl
- •oT.L.C.: _____________________ / cu.mm.
- •oD.L.C. : N ____% E ____% B ____% L ____% M _____%
- •oBleeding time------------------- Clotting time----------------------
- •oProthrombin time------------------------------------------------------
- •oHIV 1 & 2----------------------------- VDRL--------------------------
- •oHBsAg--------------------------------------------------------------------
- •oE.S.R. : _________mm (at the end of 1st hour)
- •oBlood Sugar: Fasting ____________ mg/dl.
- •oBlood Sugar :Post Prandial--------------------------------
- •ï??Bio-chemistry:
- •oBlood Urea : _________________ mg/dL
研究者
相似试验
已完成
2 期
Role of Triphaladi mouthwash in patients of dental caries.CTRI/2018/02/012165IPGT and RA40
招募中
2 期
Ayurvedic study for the treatment of ObesityCTRI/2015/09/006150Central Council for Research in Ayurvedic Sciences
已完成
2 期
Ayurvedic treatment of Allergic RhinitisCTRI/2017/12/010937CCRAS107
尚未招募
2 期
Role of ayurvedic medicine in cancerCTRI/2022/09/045590Dr Rajeev Kumar
已完成
2 期
Efficacy of Aswagandha and Mandookaparni in Manodwega (GAD) patientsCTRI/2017/07/009095Central council for Research in Ayurvedic sciences100